Sobi raises full-year revenue guidance

Statements (7)

1. ▲ Bullish

   Sobi has raised its full-year growth forecast following strong pharmaceutical sales.

   di.seOct 27, 2026 08:45 UTCHigh importance
2. ▲ Bullish

   Sobi reported third-quarter 2026 revenue of SEK 9,124 million at actual exchange rates.

   prnewswire.comOct 27, 2026 08:30 UTCHigh importance
3. ▲ Bullish

   Sobi reported third-quarter 2026 revenue of SEK 9,124 million at constant exchange rates.

   prnewswire.comOct 27, 2026 08:30 UTCHigh importance
4. ▲ Bullish

   Sobi raises its full-year guidance after exceeding analyst expectations.

   di.seOct 27, 2026 08:08 UTCHigh importance
5. ▲ Bullish

   Sobi raised its full-year 2026 revenue guidance.

   di.seOct 27, 2026 07:10 UTC
6. ▲ Bullish

   Sobi reported higher-than-expected results for the third quarter.

   di.seOct 27, 2026 07:10 UTC
7. ● Neutral

   Sobi, an investor-owned company, releases Q3 financial results during the reporting season.

   di.seOct 27, 2026 04:00 UTC